Cargando…
Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma
BACKGROUND: Malignant pleural mesothelioma (MPM) is a heterogeneous cancer. Better knowledge of molecular and cellular intra-tumor heterogeneity throughout the thoracic cavity is required to develop efficient therapies. This study focuses on molecular intra-tumor heterogeneity using the largest seri...
Autores principales: | Meiller, Clément, Montagne, François, Hirsch, Theo Z., Caruso, Stefano, de Wolf, Julien, Bayard, Quentin, Assié, Jean-Baptiste, Meunier, Léa, Blum, Yuna, Quetel, Lisa, Gibault, Laure, Pintilie, Ecaterina, Badoual, Cécile, Humez, Sarah, Galateau-Sallé, Françoise, Copin, Marie-Christine, Letouzé, Eric, Scherpereel, Arnaud, Zucman-Rossi, Jessica, Le Pimpec-Barthes, Françoise, Jaurand, Marie-Claude, Jean, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281651/ https://www.ncbi.nlm.nih.gov/pubmed/34261524 http://dx.doi.org/10.1186/s13073-021-00931-w |
Ejemplares similares
-
Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival
por: Quetel, Lisa, et al.
Publicado: (2020) -
Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications
por: Blum, Yuna, et al.
Publicado: (2019) -
High expression of spliced X-Box Binding Protein 1 in lung tumors is associated with cancer aggressiveness and epithelial-to-mesenchymal transition
por: Tavernier, Quentin, et al.
Publicado: (2020) -
Brain-derived neurotrophic factor, a new soluble biomarker for malignant pleural mesothelioma involved in angiogenesis
por: Smeele, Patrick, et al.
Publicado: (2018) -
Evolution of induction chemotherapy for non-small cell lung cancer over the last 30 years: A surgical appraisal
por: Fabre, Elizabeth, et al.
Publicado: (2015)